Valtrex is the first antiviral approved for ONE-DAY dosing in patients with cold sores
October 2002
Valtrex is the first antiviral approved for ONE-DAY dosing in patients with cold sores.
One-day dosing with Valtrex (valacyclovir) works about as well as 4 to 5 day dosing with other choices...oral Zovirax (acyclovir)...or the topical creams Abreva (docosanol) and Denavir (penciclovir).
They all reduce the duration of cold sores by about a day.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote